Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy

Study Description

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This is a pilot study to determine if there are changes in heart function following completion of radiation therapy for breast cancer as measured by cardiac magnetic resonance imaging (cardiac MRI) scans. Additional purposes of this study are to assess cardiac side effects from radiation treatment, evaluate cardiac MRI changes by radiation technique, and compare quality of life questionnaires.

Condition or disease	Intervention/treatment
Breast Cancer	Procedure: Cardiac magnetic resonance (cardiac MRI)

Detailed Description:

As part of this study, participants will have a cardiac MRI at baseline and a follow-up cardiac MRI within 1 year after completion of standard radiation therapy for left-sided breast cancer. The cardiac MRI scans will be evaluated to determine if there are changes in cardiac function within 1 year after radiation treatment.

Patients will be asked to complete a questionnaire before and after treatment that asks about their health and any symptoms they may be having.

Physical exams and any other standard of care service or treatment will be at the discretion of the treating physician.

Study Design

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Estimated Enrollment :	16 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	Prospective Pilot Study of Early Markers of Radiation-Induced Cardiac Injury in Patients With Left-Sided Breast Cancer Receiving Photon or Proton Therapy
Study Start Date :	September 2014
Estimated Primary Completion Date :	November 2018
Estimated Study Completion Date :	July 2020

Groups and Cohorts

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort	Intervention/treatment
Cardiac magnetic resonance (cardiac MRI); Participants will have a cardiac MRI at baseline and within 1 year after completion of radiation therapy.	Procedure: Cardiac magnetic resonance (cardiac MRI); Participants will have a cardiac MRI at baseline and within 1 year after completion of radiation therapy.; Other Names: Cardiac MRI; CMR

Outcome Measures

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Proportion of participants with changes in cardiac function. [ Time Frame: 1 year after completion of radiation therapy ]
   A change in cardiac function may include shifts from baseline measures of LV mass, strain, ejection fraction, and late gadolinium enhancement.

Secondary Outcome Measures :

1. Proportion of patients with serious cardiac side effects. [ Time Frame: 1 year after completion of radiation therapy ]
   Includes myocardial infarction, valve disorder, congestive heart failure, and angina.
2. Mean quality of life score. [ Time Frame: 1 year after radiation treatment ]
   Comparison of baseline and post treatment quality of life questionnaires completed by participants.

Eligibility Criteria

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Radiation oncology clinic

Criteria

Inclusion Criteria:

• Left-sided breast cancer stage I-III.
• Indications for adjuvant regional nodal and breast or chest wall radiation therapy (RT).
• Women and men are allowed.
• Must be at least 18 years old at time of consent.

Exclusion Criteria:

• Pregnant and/or breastfeeding women or patients of child-producing potential not willing to use contraception while on study.
• Prior history of cardiovascular disease per physician discretion.
• Stage 0 and IV breast cancer.
• Prior radiation therapy to chest.
• Concurrent trastuzumab per physician discretion.
• Contraindications to cardiac MRI (e.g., contrast reaction, metal implants, etc.).

Contacts and Locations

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: Intake Coordinator	877-686-6009

Locations

United States, Florida
University of Florida Proton Therapy Institute	Recruiting
Jacksonville, Florida, United States, 32206
Contact: Intake Coordinator 877-686-6009
Principal Investigator: Julie A Bradley, MD

Sponsors and Collaborators

University of Florida

Ocala Royal Dames

Investigators

Principal Investigator:	Julie A Bradley, MD	University of Florida Proton Therapy Institute

More Information

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	University of Florida
ClinicalTrials.gov Identifier:	NCT02199366 History of Changes
Other Study ID Numbers:	UFPTI 1419-BR02
First Posted:	July 24, 2014
Last Update Posted:	March 8, 2018
Last Verified:	March 2018

Studies a U.S. FDA-regulated Drug Product:		No
Studies a U.S. FDA-regulated Device Product:		No

Keywords provided by University of Florida:

Cardiac MRI; Radiation; Proton Radiation; Breast Cancer

Additional relevant MeSH terms:

Breast Neoplasms; Unilateral Breast Neoplasms; Neoplasms by Site	Neoplasms; Breast Diseases; Skin Diseases